<DOC>
	<DOCNO>NCT01837719</DOCNO>
	<brief_summary>The purpose study compare pharmacokinetics bioequivalence atazanavir fixed-dose combination cobicistat atazanavir coadministered cobicistat single agent .</brief_summary>
	<brief_title>Bioequivalence Study Individual Atazanavir Cobicistat Compared With Atazanavir Fixed-dose Combination With Cobicistat</brief_title>
	<detailed_description />
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Cobicistat</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<criteria>Key Healthy men woman , age 18 49 year Body mass index 18 32 kg/m^2 , inclusive Women childbearing potential ( WOCBP ) pregnant breastfeed WOCBP men sexually active WOCBP must use acceptable contraceptive method Key Any significant acute chronic medical illness Current recent ( within 3 month study drug administration ) gastrointestinal tract disease Any major surgery within 4 week study drug administration Any gastrointestinal tract surgery ( include cholecystectomy ) could impact absorption study drug Donation blood blood bank clinical study ( except screen visit ) within 4 week study drug administration ( within 2 week plasma ) Blood transfusion within 4 week study drug administration Inability tolerate oral medication , venipunctured , tolerate venous access Evidence organ dysfunction clinically significant deviation normal physical examination electrocardiogram ( ECG ) finding , vital sign measurement , result clinical laboratory test , beyond consistent target population Any follow 12lead ECG finding prior study drug administration , confirm repeat test PR ≥210 msec QRS ≥120 msec QT ≥500 msec QTcF ≥450 msec 2nd 3rddegree AV block clinically relevant abnormality ECG finding Positive result urine screening drug abuse Positive result blood screen hepatitis C antibody , hepatitis B surface antigen , HIV1 2 antibody Laboratory test result indicate level outside range specify : Alanine aminotransferase &gt; upper limit normal ( ULN ) Aspartate aminotransferase &gt; ULN Total bilirubin &gt; ULN Serum creatinine &gt; ULN</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>